Patents by Inventor Louis C. Sanfilippo

Louis C. Sanfilippo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130213851
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Application
    Filed: August 21, 2012
    Publication date: August 22, 2013
    Applicant: CENESTRA LLC.
    Inventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
  • Publication number: 20120172431
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Application
    Filed: December 5, 2011
    Publication date: July 5, 2012
    Applicant: CENESTRA LLC
    Inventors: Seth D. Feuerstein, Ann CORIC, Louis C. Sanfilippo
  • Publication number: 20110303573
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Application
    Filed: June 27, 2011
    Publication date: December 15, 2011
    Applicant: CENESTRA LLC
    Inventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
  • Patent number: 8071646
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Grant
    Filed: October 28, 2009
    Date of Patent: December 6, 2011
    Assignee: Cenestra LLC
    Inventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo
  • Publication number: 20100130611
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Application
    Filed: January 25, 2010
    Publication date: May 27, 2010
    Applicant: CENESTRA LLC
    Inventors: Seth D. FEUERSTEIN, Ann Coric, Louis C. Sanfilippo
  • Patent number: 7652068
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Grant
    Filed: December 20, 2006
    Date of Patent: January 26, 2010
    Assignee: Cenestra LLC
    Inventors: Seth Feuerstein, Ann Coric, Louis C. Sanfilippo
  • Publication number: 20080268042
    Abstract: The present invention provides highly purified omega-3 fatty acid formulations. Certain formulations provided herein have contain greater than 85% omega-3 fatty acids by weight. Certain other formulations provided herein contain EPA and DHA in a ratio of from about 4.01:1 to about 5:1. The invention also provides methods of using the dosage forms to treat a variety of cardiovascular, autoimmune, inflammatory, and central nervous system disorders by administering a formulation of the invention to a patient in need thereof.
    Type: Application
    Filed: July 9, 2008
    Publication date: October 30, 2008
    Applicant: CENESTRA LLC
    Inventors: Seth D. Feuerstein, Ann Coric, Louis C. Sanfilippo